Does a multiple myeloma patient whose disease has relapsed, need to undergo a 2nd ASCT? (https://www.myeloma.org/videos/does-multiple-myeloma-patient-whose-disease-has-relapsed-need-undergo-2nd-asct)
In this week’s video, Dr. Brian G.M. Durie discusses other options to consider if your doctor recommends a second autologous stem cell transplant.
BOTTOM LINE:
Discuss with your doctor the benefits and side effects of a second transplant as opposed to immune therapies and immune therapy combinations.
Ask a Question
Please note that Ask Dr. Durie has been discontinued, and it was designed to address myeloma questions of the broadest possible audience interest. If you have a question of a personal nature, please contact our InfoLine Coordinators at 800.452.2873 or [email protected] (mailto:[email protected]) (Please do not send email attachments or lab reports.).
Dr. Brian G.M. Durie (1942-2025) was the co-founder of the IMF. He was a Professor of Medicine, Hematologist/Oncologist, and Honoree MD at the University of Brussels.